← FDA Drug Approvals (Drugs@FDA)

DEXILANT SOLUTAB

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2016-01-26

Drug application

FDA Application #

NDA208056

Application type

New Drug Application

Brand name

DEXILANT SOLUTAB

Generic name

Dexlansoprazole

Active ingredients

DEXLANSOPRAZOLE

Dosage form

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

TAKEDA PHARMS USA

First approval

2016-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown